Condition
Amyloid Beta-Peptides
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Amyloid Brain Imaging And Alzheimers Disease Risk Disclosure
Research Leaders
6 sponsors active, led by University of Michigan
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Amyloid Brain Imaging And Alzheimers Disease Risk Disclosure1
- Alzheimers Disease Risk Disclosure1
Active Sponsors
- University of Michigan1
- University of Pennsylvania1
- National Institute on Aging (NIA)1
- Duke University1
- Boston University1
Top Investigators
Brigham and Women's Hospital
Duke University
University of Pennsylvania
University of Michigan
Related Conditions
- Risk Assessment1
- Alzheimer Disease1
- Neuroimaging1
- Education1
- Neuropsychological Tests1